StocksMarket.in

IPO

 Breaking News
  • No posts where found

Mindspace Business Parks REIT zooms over 10% in debut trade

The Rs 4,500-crore public issue of Mindspace Business Parks REIT was subscribed nearly 13 times late last month. Mindspace Business Parks REIT made its market debut on Friday and closed

Read Full Article

Mindspace REIT lists at 11% premium on issue price of Rs 275

K Raheja Corp and Blackstone-backed Mindspace Business Parks REIT listed with a 10.55 percent premium over its issue price of Rs 275, at Rs 304 on BSE on August 7.

Read Full Article

Mindspace Business Parks REIT to debut on August 7, issue price set at Rs 275 per share

K Raheja Corp and Blackstone-backed Mindspace Business Parks REIT is set to debut on bourses on August 7 after receiving good response from institutional as well as non-institutional investors. The

Read Full Article

Mindspace Business Parks REIT IPO subscribed 13 times on final day

The Rs 4,500-crore IPO of Mindspace Business Parks REIT has been received very well by investors as the bidding ended July 29. The public issue has been subscribed 12.96 times,

Read Full Article

Mindspace Business Parks REIT IPO fully subscribed on second day

The Rs 4,500-crore public offer of Mindspace Business Parks REIT has been fully subscribed on July 28, the second day of its bidding, driven by the demand from non-institutional investors.

Read Full Article

Mindspace Business Parks REIT IPO subscribed 38% on Day 1

Mindspace Business Parks REIT’s initial public offering has subscribed 38 percent on July 27, the first day of bidding. The public issue has received bids for 2,59,22,800 units against offer

Read Full Article

IIFL Securities recommends subscribing to Mindspace Business Parks REIT IPO; here#39;s why

The Rs 4,500-crore initial public offering (IPO) of Mindspace Business Parks REIT, backed by K Raheja group and Blackstone, will

Read Full Article

Mindspace Business Parks REIT IPO opens on July 27; here are 10 things you should know

The public offer of Mindspace Business Parks REIT is set to open for subscription on July 27 and the closing

Read Full Article

3 Point Analysis | Rossari Biotech#39;s stellar listing: What should investors do now?

The stock opened with a premium of Rs 245, or 58 percent, on the BSE against its issue price of

Read Full Article

Rossari Biotech debuts at Rs 670 with 58% premium over IPO price

The Mumbai-based specialty chemical maker Rossari Biotech started the first trading day with a whopping 57.65 percent premium over its

Read Full Article

Yes Bank FPO subscribed 95% so far, QIB remains strong on final day

The follow-on public offer of Yes Bank has been subscribed 92.75 percent so far on final day of bidding, July 17.

Read Full Article

Subscribe to Rossari Biotech: Ajcon Research

Ajcon Research Rossari Biotech Started in CY03 as “Rossari Lab tech”, a partnership firm, Rossari was converted to Company in

Read Full Article

Subscribe to Rossari Biotech: Choice Equity Broking

Choice Equity Broking has come out with its report on Rossari Biotech. The research firm has recommended to “Subscribe” the

Read Full Article

Subscribe to Rossari Biotech: Anand Rathi

Anand Rathi has come out with its report on Rossari Biotech. The research firm has recommended to “Subscribe” the IPO

Read Full Article

Subscribe to Rossari Biotech: Hem Securities

Hem Securities has come out with its report on Rossari Biotech. The research firm has recommended to “Subscribe” the IPO

Read Full Article

Rossari Biotech#39;s Rs 496-crore IPO subscribed 79 times so far on last day

The Rs 496-crore public offer of Rossari Biotech, a specialty chemical maker, has received overwhelming response from investors as it

Read Full Article

Rossari Biotech#39;s Rs 496-crore IPO subscribed 38 times so far on last day

The Rs 496-crore public offer of Rossari Biotech, a specialty chemical maker, has been subscribed 38 times till morning of

Read Full Article

Subscribe to Rossari Biotech: Arihant Capital

Arihant Capital has come out with its report on Rossari Biotech. The research firm has recommended to “Subscribe” the IPO

Read Full Article

Subscribe to Rossari Biotech: Mehta Equities

Mehta Equities has come out with its report on Rossari Biotech. The research firm has recommended to “Subscribe” the IPO

Read Full Article

Archives